Proteomics International raises $6m in heavily oversubscribed Placement

Funds from the Placement will be used for:

  • Manufacture & up-scaling of reagent inventory for the PromarkerD predictive test
  • Marketing of, and accelerating regulatory approvals for PromarkerD
  • Accelerating the development and commercialisation of the Company’s Promarker™ pipeline
  • Strengthening the Company’s balance sheet for future licensing negotiations
  • General working capital


Media Release

  • This field is for validation purposes and should be left unchanged.